Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	46,381	43,399	50,869	44,662	56,329	47,893
Market Cap Growth	-6.57%	-14.68%	13.90%	-20.71%	17.61%	-24.50%
Enterprise Value	81,089	75,918	81,755	74,563	98,218	94,787
Last Close Price	15.18	13.63	15.65	13.11	16.08	12.88
PE Ratio	35.05	45.57	21.33	23.57	16.57	116.48
PS Ratio	1.59	1.54	1.68	1.52	1.95	1.57
PB Ratio	0.98	0.90	1.06	0.95	1.20	1.09
P/FCF Ratio	7.24	12.14	8.08	5.42	6.92	9.50
P/OCF Ratio	6.55	9.16	6.92	4.83	6.16	7.69
EV/Sales Ratio	2.78	2.69	2.70	2.54	3.40	3.10
EV/EBITDA Ratio	10.08	10.09	8.98	7.65	11.04	11.59
EV/EBIT Ratio	21.62	23.28	17.54	15.09	25.62	34.38
EV/FCF Ratio	12.66	21.23	12.99	9.06	12.07	18.80
Debt / Equity Ratio	0.73	0.75	0.77	0.85	0.98	1.16
Debt / EBITDA Ratio	4.13	4.60	3.86	4.07	5.16	6.21
Debt / FCF Ratio	5.92	10.10	5.81	4.81	5.64	10.07
Asset Turnover	0.31	0.29	0.30	0.27	0.25	0.25
Inventory Turnover	1.31	1.30	1.36	1.40	1.34	1.33
Quick Ratio	0.59	0.50	0.49	0.73	1.00	0.65
Current Ratio	1.31	1.11	0.97	1.21	1.53	1.14
Return on Equity (ROE)	2.94%	2.12%	5.27%	4.24%	7.60%	0.89%
Return on Assets (ROA)	2.51%	2.12%	2.85%	2.88%	2.06%	1.39%
Return on Capital (ROIC)	2.97%	2.57%	3.57%	3.62%	2.59%	1.74%
Return on Capital Employed (ROCE)	4.50%	3.90%	5.40%	5.40%	3.80%	2.80%
Earnings Yield	2.85%	2.20%	4.69%	4.24%	6.04%	0.86%
FCF Yield	13.81%	8.24%	12.37%	18.44%	14.44%	10.53%
Dividend Yield	3.88%	9.12%	8.65%	11.30%	10.12%	12.99%
Payout Ratio	71.16%	199.34%	88.14%	123.30%	75.36%	638.73%
Buyback Yield / Dilution	-1.17%	-0.67%	0.46%	-0.23%	-0.47%	-61.98%
Total Shareholder Return	2.71%	8.45%	9.12%	11.07%	9.65%	-48.99%

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q